ACHIEVE is a multi-stakeholder coalition united in the fight against viral hepatitis B and C.

The ACHIEVE ambition is to see the elimination of viral hepatitis in Europe by 2030.

 

Our Position Statement

 

Time for the EU to act on viral hepatitis elimination

Professor David Goldberg (Health Protection Scotland) & experts of the ACHIEVE coalition explain what stands in the way of hepatitis elimination and why and how the EU must step up to drive forward WHO goals, which build on the UN SDG. Professor Goldberg also explains what makes the Scottish Hepatitis C Plan so successful and what are the learnings from HIV. Please listen to them and spread the word!

Prof. Pierre Van Damme
Scientific Secretariat, Viral Hepatitis Prevention Board (VHPB); ACHIEVE member

Greet Hendrickx
Scientific Secretariat, Viral Hepatitis Prevention Board (VHPB); ACHIEVE member

Prof. Massimo Colombo
Chairman of the EASL International Liver Foundation; ACHIEVE member

Prof. David Goldberg
Clinical Epidemiologist and Consultant in Public Health Medicine, Health Protection Scotland

Tatjana Reic   European Liver Patients’ Association (ELPA), ACHIEVE Chair
Luis Mendao   European AIDS Treatment Group (EATG), ACHIEVE Vice-Chair
Marko Korenjak   European Liver Patients’ Association (ELPA), ACHIEVE Member
Eberhard Schatz   Correlation – European Harm Reduction Network, ACHIEVE Member

“Hepatitis mortality is higher than that from HIV and TB combined. HIV has shown us what we can achieve if we put our minds to it. It’s very exciting to take viral hepatitis towards that as well: it’s for public health and clinicians to work together, close the data gaps and realise we are working towards the same goal.”

 

 

Lina Nerlander, surveillance expert for hepatitis B and C surveillance at the European Centre for Disease Prevention and Control (ECDC) explains why the EU needs to close the data gap on hepatitis in order to meet the 2030 elimination goals. Mortality rates from hepatitis are higher in the European Region than those from HIV and tuberculosis combined.

 

Collecting data along the continuum of care, similar to what has been done in the field of HIV, is the key to finding the ‘missing millions’ of people who are still undiagnosed and unaware of their condition. It enables countries to assess progress while they work towards hepatitis elimination. Clinicians and public health authorities from all Member States need to work together to close the data gap and make hepatitis elimination a reality.

 

 

New EU legislature

This year’s Spring Testing Week overlapped with another important event: The European Parliament elections from 22 to 26 May. Watch and listen to ACHIEVE’s message to the new EU policymakers.

 

As a coalition, we come together to speak with one voice.

We represent patients and community, clinicians and researchers.

 

Contact Us

 

Our Members

The ACHIEVE coalition presently includes the following organisations.
It is enabled by the support of Abbott, AbbVie, CEPHEID and Gilead Sciences.

Chair

Tatjana Reic, President of the European Liver Patients’ Association (ELPA)